Company Search:
Advanced Search
Sponsored Links
Biofrontera AG Company Snapshot
Biofrontera AG operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biofrontera AG with three other pharmaceutical manufacturers in Europe: Pierrel of Italy (2018 sales of 19.93 million Euro [US$22.09 million] ), Photocure ASA of Norway (181.51 million Norwegian Kroner [US$19.77 million] of which 61% was Hexvix/Cysview Own Sales), and Vistin Pharma ASA which is also based in Norway (198.99 million Norwegian Kroner [US$21.67 million] of which 101% was Pharmaceuticals).

Sales Analysis. Biofrontera AG reported sales of 21.11 million Euro (US$23.40 million) for the year ending December of 2018. This represents an increase of 75.5% versus 2017, when the company's sales were 12.03 million Euro. This was the fourth straight year of sales growth at Biofrontera AG.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Biofrontera AG
  Stock Performance Chart for Biofrontera AG
  Stock Data: Recent Stock Performance:
  Current Price (11/29/2019): 4.70
(Figures in Euro)
1 Week 10.6%   13 Weeks -9.1%  
4 Weeks -28.6%   52 Weeks -13.8%  
Biofrontera AG Key Data:
  Ticker: B8F Country: Germany
  Exchanges: FRA Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 21,107,000
(Year Ending Jan 2019).
Employees: 157
  Currency: Euro Market Cap: 210,792,016
  Fiscal Yr Ends: December Shares Outstanding: 44,849,365
  Share Type: Stammaktie Closely Held Shares: 23,609,061
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.